2010
DOI: 10.3109/10731199.2010.494578
|View full text |Cite
|
Sign up to set email alerts
|

Advances in Novel Drug Delivery Strategies for Breast Cancer Therapy

Abstract: Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this colleolion of information, including suggestions for reducing this burden to Washington Headquarters Services, Directorate for Information Operations and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
75
0
1

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 104 publications
(81 citation statements)
references
References 98 publications
0
75
0
1
Order By: Relevance
“…Nowadays, chemotherapy is the most commonly used treatment in the therapeutic approach; however, conventional chemotherapy has shown low efficacy when the disease is not treated in early stages [2]. As a matter of fact, chemotherapy drugs are not specific and act both on tumor and normal cells, causing side effects [3].…”
Section: Introductionmentioning
confidence: 99%
“…Nowadays, chemotherapy is the most commonly used treatment in the therapeutic approach; however, conventional chemotherapy has shown low efficacy when the disease is not treated in early stages [2]. As a matter of fact, chemotherapy drugs are not specific and act both on tumor and normal cells, causing side effects [3].…”
Section: Introductionmentioning
confidence: 99%
“…58 The combinations of doxorubicin and cyclophosphamide utilizing non-PEGylated liposomes were used for the treatment of metastatic breast cancer. 59 Moreover, liposome-conjugated antibody that overexpresses the HER-2 has been developed and reported as delivering 22-fold more calcein to mammary epithelial cells. 60 The synergistic effects of combined drug delivery of quercetin and vincristine through liposomes were reported for treatment of ER-negative breast cancer.…”
mentioning
confidence: 99%
“…Such nanomaterials are: lipids, polymers, protein, dendrimers, metallic or silicon nanoparticles, and quantum dots [40]. The last decades, with the rapid development of the nanotechnology, a revolutionary growth of alternative methods have been proposed using multifunctional nanosystems, which have multiple functions: early cancer detection, targeted drug delivery, and monitoring the cancer progression.…”
Section: Drug Delivery Nanosystems (Ddnss) and Photodynamic Therapy (mentioning
confidence: 99%